Apogee Therapeutics, Inc. - Common Stock (APGE)

Historical Holders from Q3 2023 to Q4 2025

Symbol: APGE on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 46,121,838
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 59,584,018
Holdings value: $2,367,665,565
% of all portfolios: 0%
Number of holders: 172
Number of buys: 85
Number of sells: 89
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock (APGE) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	15%		$273,383,018		6,907,100		FMR LLC	30 Jun 2025
Fairmount Funds Management LLC	10%		$229,546,677		5,776,881		Peter Evan Harwin	10 Oct 2025
WELLINGTON MANAGEMENT GROUP LLP	11%	+29%	$193,354,079	+$42,724,077	4,885,146	+28%	Wellington Management Group LLP	31 Jul 2025
RTW INVESTMENTS, LP	6%		$86,244,685		2,712,097		RTW Investments, LP	31 Dec 2024
BlackRock, Inc.	5.5%		$99,691,136		2,518,725		BlackRock, Inc.	30 Jun 2025
DRIEHAUS CAPITAL MANAGEMENT LLC	4.7%		$85,757,284		2,158,502		DRIEHAUS CAPITAL MANAGEMENT LLC	30 Sep 2025

As of 30 Sep 2025 Apogee Therapeutics, Inc. - Common Stock (APGE) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 59,584,018 shares of the company stock as of 30 Sep 2025.

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock (APGE) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	216	$16,304	+$5,510			$75.48	1
2025 Q3	59,584,018	$2,367,665,565	+$56,490,678	$4,938,439	$12,022,298	$39.73	172
2025 Q2	57,837,483	$2,511,890,310	-$147,323,035	$16,720,550	$17,267,768	$43.43	180
2025 Q1	61,488,037	$2,301,755,045	+$131,273,428	$9,407,248	$13,823,200	$37.36	165
2024 Q4	57,873,775	$2,621,627,156	+$63,332,211	$3,216,300	$1,617,210	$45.30	156
2024 Q3	56,092,373	$3,292,239,808	+$134,061,710	$15,237,156	$2,637,426	$58.74	139
2024 Q2	54,153,585	$2,130,950,611	-$9,265,142	$637,470	$86,570	$39.35	137
2024 Q1	52,903,025	$3,515,414,886	+$773,333,688	$338,895	$4,511,955	$66.45	138
2023 Q4	26,497	$740,326	+$740,326			$27.94	2
2023 Q3	40,108,316	$848,591,959	+$848,589,611			$21.30	72